August 14, 2012 — Berlin Heart announced that a study recently published in the New England Journal of Medicine (NEJM) concluded that survival using the Excor pediatric ventricular assist device (VAD) is "significantly greater" than the standard-of-care (extracorporeal membrane oxygenation, or ECMO) as a bridging therapy for children in need of a heart transplant.

August 14, 2012 — A study led by Kavitha Chinnaiyan, M.D., director of advanced cardiac imaging education, Beaumont Health System (Mich.), has shown that inappropriate CCTA (coronary computed tomography [CT] angiography) use can be reduced by 60 percent with educational programs, increased physician collaboration and close monitoring.

August 14, 2012 — The next five years will see many hospitals in Europe overcoming the high cost and complexity of implementing hybrid operating rooms (OR) by adopting better planning and budget allocation. This will encourage hospitals with larger cardiac and neurosurgery services to implement at least one hybrid OR, suggests new analysis from Frost & Sullivan.

August 14, 2012 — The U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance to Stryker Neurovascular’s Trevo Pro Retriever, indicated for the removal of blood clots. It uses Stentriever technology to optimized clot integration and retrieval in patients experiencing acute ischemic stroke.

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical operations from the Crown Point, Ind. facility to its Lubbock, Texas site.

Biosense Webster Inc. launched the new Carto 3 MEM (Multi-Electrode Mapping) Version in the United States. It is the latest advancement on the Carto 3 system platform.

August 14, 2012 — The U.S. Food and Drug Administration (FDA) is hosting a public workshop that examines use of absorbable materials in implantable devices for endovascular therapies such as fully absorbable cardiovascular stents, where the stent platform degrades, as well as absorbable coatings.

McKesson released its Cardiology 13.0 system, which offers a single database solution for cardiac and peripheral catheterization, hemodynamic monitoring, electrophysiology (EP), echocardiography, vascular ultrasound, nuclear cardiology and electrocardiogram (ECG), ECG stress and Holter management. Data entered at any point-of-care flows into the electronic health record (EHR) without the need for potentially cumbersome interfaces or redundant documentation.  This latest release is designed to boost clinical efficiencies and reduce operational costs. 

August 13, 2012 — Analog Devices Inc. (ADI) has introduced a low-power, single-lead, heart rate monitor analog front end (AFE) for a wide range of vital sign monitoring applications. The AD8232 AFE is 50 percent smaller and uses up to 20 percent less power than other solutions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now